Search - tctmd.com

Displaying 21 - 40 of 96

Sort: Relevancy | Date

Presentation NY Valves 2024

CON: M-TEER for ALL Phenotypes – Symptomatic Improvement Is Enough

Presenter: Michael Joseph Rinaldi

June 06, 2024

Presentation NY Valves 2024

PRO: M-TEER for COAPT-Eligible Patients Only – The Evidence is Clear

Presenter: JoAnn Lindenfeld

June 06, 2024

Presentation NY Valves 2024

The Heterogeneity of Functional MR: Phenotype Clusters and Implications for Management

Presenter: Anna Sannino

June 06, 2024

Presentation NY Valves 2024

Secondary MR and GDMT Titration Before M-TEER in the Real-world

Presenter: Donna Mancini

June 05, 2024

Presentation TCT 2023

Case-Based: Patient Selection for Mitral Transcatheter Edge-to-Edge Repair in Secondary MR – Turning Controversy Into Learning

Presenter: Federico Asch

October 24, 2023

Presentation TCT 2023

Mitral Transcatheter Edge-to-Edge Repair for Secondary MR in the Management of HFrEF: Where Does It Fit in?

Presenter: Marianna Adamo

October 24, 2023

Presentation TCT 2023

Will Advances in GDMT Reduce Need for Mitral TEER in Secondary MR?

Presenter: JoAnn Lindenfeld

October 24, 2023

Presentation TCT 2023

My 5 Key Features for Morphological Suitability of Mitral Transcatheter Edge-to-Edge Repair in Primary MR

Presenter: Sam Dawkins

October 24, 2023

Presentation TCT 2023

Mitral Transcatheter Edge-to-Edge Repair in Intermediate and Low-Risk Patients: Rationale, Evidence, and Ongoing Studies

Presenter: Gorav Ailawadi

October 24, 2023

Presentation TCT 2023

Current Evidence for M-Transcatheter Edge-to-Edge Repair in Primary MR

Presenter: Khung Keong Yeo

October 24, 2023

Presentation TCT 2023

Atrial Secondary MR or TR in HFpEF: How to Treat

Presenter: Sanjiv Shah

October 24, 2023

Presentation TVT 2023

Case Resolution: Management of Advanced HF in a Patient with Severe Secondary MR

Presenter: Michael Brener

June 08, 2023

Presentation TVT 2023

Case Presentation: Management of Advanced HF in a Patient with Severe Secondary MR

Presenter: Michael Brener

June 08, 2023

Presentation TVT 2023

M-TEER in Secondary MR: Time to Re-Evaluate Timing and Patient Selection?

Presenter: Niklas Schofer

June 08, 2023

Presentation TVT 2023

M-TEER in Atrial Functional MR in HFpEF Patients

Presenter: Philipp Lurz

June 08, 2023

Presentation TVT 2023

M-TEER in Severe LV Dysfunction as a Bridge to Advanced HF Therapies

Presenter: Mark Reisman

June 08, 2023

Presentation TVT 2023

Correcting MR Severity is the #1 Priority! - GDMT Optimization Will Always Follow

Presenter: Amar Krishnaswamy

June 08, 2023

Presentation TVT 2023

GDMT First! – M-TEER is Indicated Only After GDMT is Optimized

Presenter: Colin Barker

June 08, 2023

Presentation TVT 2023

SPOTLIGHT LECTURE: TEER in Secondary MR- Clinical Evidence, Patient Selection, and Controversies

Presenter: Philipp Lurz

June 08, 2023

Presentation TVT 2023

M-TEER in HF Patients With Secondary MR: A “Foundational” or Bridge Therapy?

Presenter: Paul Grayburn

June 08, 2023

Advertisement

CON: M-TEER for ALL Phenotypes – Symptomatic Improvement Is Enough

PRO: M-TEER for COAPT-Eligible Patients Only – The Evidence is Clear

The Heterogeneity of Functional MR: Phenotype Clusters and Implications for Management

Secondary MR and GDMT Titration Before M-TEER in the Real-world

Case-Based: Patient Selection for Mitral Transcatheter Edge-to-Edge Repair in Secondary MR – Turning Controversy Into Learning

Mitral Transcatheter Edge-to-Edge Repair for Secondary MR in the Management of HFrEF: Where Does It Fit in?

Will Advances in GDMT Reduce Need for Mitral TEER in Secondary MR?

My 5 Key Features for Morphological Suitability of Mitral Transcatheter Edge-to-Edge Repair in Primary MR

Mitral Transcatheter Edge-to-Edge Repair in Intermediate and Low-Risk Patients: Rationale, Evidence, and Ongoing Studies

Current Evidence for M-Transcatheter Edge-to-Edge Repair in Primary MR

Atrial Secondary MR or TR in HFpEF: How to Treat

Case Resolution: Management of Advanced HF in a Patient with Severe Secondary MR

Case Presentation: Management of Advanced HF in a Patient with Severe Secondary MR

M-TEER in Secondary MR: Time to Re-Evaluate Timing and Patient Selection?

M-TEER in Atrial Functional MR in HFpEF Patients

M-TEER in Severe LV Dysfunction as a Bridge to Advanced HF Therapies

Correcting MR Severity is the #1 Priority! - GDMT Optimization Will Always Follow

GDMT First! – M-TEER is Indicated Only After GDMT is Optimized

SPOTLIGHT LECTURE: TEER in Secondary MR- Clinical Evidence, Patient Selection, and Controversies

M-TEER in HF Patients With Secondary MR: A “Foundational” or Bridge Therapy?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content